BIIB241213P245000
- 0.00
- 0.000.00%
Biogen Newsroom
Palantir, MicroStrategy Could Be Added to Nasdaq 100 Friday. Moderna, Super Micro Could Be Dropped.
Market Mixed on Friday the 13th | Livestock
Biogen Stock Touches 52-week Low at $153.55 Amid Challenges
Biogen ALS Drug Needs to Be Covered by MA Plans, CMS Says
Thursday Ends in Index Declines | Wall Street Today
Is Biogen Inc.'s (NASDAQ:BIIB) Stock Price Struggling As A Result Of Its Mixed Financials?
Market Falls Thursday, Producer Inflation Grows, and Tech Pulls Back From Records | LiveStock
N-Lorem Foundation's Nano-rare Patient Colloquium Draws More Than 750 Attendees, Reinforcing Need for Treatment Options for People With Nano-rare Illnesses
Super Micro Computer Teeters On Edge Of Nasdaq 100: Can XAI, Nvidia Help Stabilize Trajectory?
MicroStrategy Stock Could Get Added to the Nasdaq 100 Because of a Quirk
Market Climbs on CPI Inflation and Likelihood of Rate Cuts | Livestock
Biogen Reinstated With a Neutral at BofA
BofA Restarts Coverage of 11 Large-cap Biopharmas
Market Falls Wednesday, but Googles Chip Impresses | WST
Google's Quantum Chip Might Have Contacted Parallel Universes | Live Stock
B of A Securities Reinstates Neutral on Biogen, Announces $178 Price Target
Insider Sale: Head of Development of $BIIB (BIIB) Sells 110 Shares
Biogen Downgraded On Pipeline Setbacks And Leqembi Sales Slowdown
Biogen Cut at Jefferies as '2025 Has a Tough Setup'
Monday Market Falls, Chinese Stocks Climb, Indices Rebalance | Live Stock